We work to improve the health and quality of life of the very youngest
Pathologies of the foetus and psychiatric disorders are some of the lines of research we support in order to improve children’ physical and mental health.
Infants who have suffered delayed growth at the foetal stage may display anomalous brain development that leads to learning difficulties. It is critical to detect these problems early in order to combat their effects and improve the infants’ quality of life.
Since 2010 we have worked with the Hospital Clínic de Barcelona on research into new technologies to allow early diagnosis and identification of possible therapeutic targets. This centre, which has become a leader in its field together with those in Detroit, London, Louvain and Paris, conducts about two hundred interventions a year on pregnant women from all over the world.
Enhancement of care to adolescents and young people with borderline personality disorder (BPD) – Vall d'Hebron Hospital
This project, led by Dr Miguel Casas, aims to improve the attention of adolescents and young people with borderline personality disorder (BPD) from a comprehensive global standpoint, and to guarantee on-going assistance in the care process.
The programme assesses the outcome of the treatment and monitoring of patients, the performance of cost-effectiveness studies in the interventions and the preparation of leading diagnostic tools for attention deficit hyperactivity disorder (ADHD), and the performance of genetic studies in patients.
MAS Casadevall Foundation - Autism
The Mas Casadevall Autism Foundation aims to provide comprehensive support to those with autism spectrum disorders (ASD) and to offer life and work spaces to young people and adults seriously affected by autism.
The ”la Caixa” Foundation supports the Mas Casadevall Foundation through two grants for the training of researchers in autism spectrum disorders at the Mind Institute (Medical Investigation of Neurodevelopmental Disorders) in California, USA, one of the reference centres in the treatment of autism at international level.
Dravet syndrome is one of the most serious epileptic encephalopathies in children. It is characterised by frequent, long-lasting convulsions which appear between the ages of four and six months in apparently healthy children and are associated with subsequent intellectual deterioration and behaviour disorders. There is currently no specific treatment and the habitual treatment for epilepsy makes the symptoms worse.
The aim of this project, led by doctor Gloria González-Aseguinolaza, are to analyse how this illness responds to gene therapy and to establish the parameters for getting clinically significant results.